Sonoma Pharmaceuticals, Inc. (SNOA) Insider Trading Activity

NASDAQ$1.12-0.02 (-1.75%)
Market Cap
$5.46M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
777 of 849
Rank in Industry
42 of 48

SNOA Insider Trading Activity

SNOA Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About Sonoma Pharmaceuticals, Inc.

Sonoma Pharmaceuticals, Inc. specializes in the creation and distribution of stabilized hypochlorous acid (HOCl) products. These offerings address a diverse range of medical and health needs, including wound management, veterinary care, ocular hygiene, oral health, and various dermatological conditions. The company's market reach extends across the United States, Latin America, Europe, and other international territories. Its comprehensive product line features: Epicyn: an antimicrobial cleanser for facial use. Levicyn: a prescription …

Insider Activity of Sonoma Pharmaceuticals, Inc.

Over the last 12 months, insiders at Sonoma Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Sonoma Pharmaceuticals, Inc. stock.

On average, over the past 5 years, insiders at Sonoma Pharmaceuticals, Inc. have bought $0 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 1,200 shares for transaction amount of $4,920 was made by Miller Robert E (Chief Financial Officer) on 2018‑03‑13.

List of Insider Buy and Sell Transactions, Sonoma Pharmaceuticals, Inc.

2018-03-13PurchaseMiller Robert EChief Financial Officer
1,200
0.027%
$4.10
$4,920
-55.97%
2018-03-12PurchaseMiller Robert EChief Financial Officer
2,400
0.0536%
$4.03
$9,672
-55.28%
2018-03-09PurchaseMiller Robert EChief Financial Officer
1,200
0.0255%
$3.90
$4,680
-55.56%
2018-03-08PurchaseSchutz James JChief Executive Officer
2,473
0.0572%
$3.99
$9,867
-52.76%
2017-11-30PurchaseSchutz James JChief Executive Officer
345
0.0079%
$4.95
$1,708
-24.44%
2017-11-29PurchaseSchutz James JChief Executive Officer
400
0.0091%
$5.03
$2,012
-25.41%
2017-11-29PurchaseMiller Robert EChief Financial Officer
1,790
0.0408%
$5.02
$8,991
-25.41%
2017-11-24PurchaseSchutz James JChief Executive Officer
254
0.0057%
$5.05
$1,283
-26.71%
2017-11-21PurchaseMiller Robert EChief Financial Officer
2,000
0.0455%
$5.03
$10,065
-25.20%
2017-08-10PurchaseSchutz James JChief Executive Officer
929
0.0228%
$5.46
$5,069
-16.31%
2017-08-10PurchaseMiller Robert EChief Financial Officer
2,264
0.054%
$5.30
$11,999
-16.31%
2017-08-10PurchaseUmscheid MarcChief Strategy/Mkt Officer
600
0.0143%
$5.31
$3,186
-16.31%
2017-03-09PurchaseMiller Robert EChief Financial Officer
750
0.0178%
$7.02
$5,268
-21.00%
2017-03-08PurchaseMiller Robert EChief Financial Officer
1,000
0.0235%
$6.93
$6,930
-20.36%
2017-03-06PurchaseUmscheid MarcChief Strategy/Mkt Officer
750
0.0176%
$6.82
$5,115
-18.90%
2017-03-03PurchaseSchutz James JChief Executive Officer
800
0.0189%
$6.78
$5,421
-17.16%
2016-12-08PurchaseSchutz James JChief Executive Officer
1,000
0.0238%
$4.88
$4,880
+34.54%
2016-12-08PurchaseMiller Robert EChief Financial Officer
5,000
0.1186%
$4.86
$24,300
+34.54%
2016-08-15PurchaseSchutz James JChief Executive Officer
1,328
0.0306%
$3.66
$4,866
+72.16%
2016-02-25PurchaseSchutz James JChief Executive Officer
5,000
0.0304%
$1.00
$5,000
-4.00%
Total: 42

SNOA Institutional Investors: Active Positions

Increased Positions5+17.86%55,935+94.23%
Decreased Positions11-39.29%6,382-10.75%
New Positions2New11,693New
Sold Out Positions6Sold Out1,432Sold Out
Total Postitions22-21.43%108,914+83.48%

SNOA Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Vanguard Group Inc$76.001.04%20,873+20,873New2025-09-30
Geode Capital Management, Llc$64.000.88%17,61700%2025-09-30
Drw Securities, Llc$62.000.85%17,070+17,070New2025-09-30
Tower Research Capital Llc (Trc)$6.000.08%1,536+536+53.6%2025-09-30
Citigroup Inc$2.000.03%656+656New2025-09-30
Rockefeller Capital Management L.P.$2.000.03%646+646New2025-09-30
Global Retirement Partners, Llc$2.000.02%438+438New2025-09-30
Mai Capital Management$00.01%124+124New2025-09-30
Jpmorgan Chase & Co$00.01%123+3+2.5%2025-09-30
Blackrock, Inc.$00.01%11300%2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.